Natascha Hermann-Kleiter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Natascha Hermann-Kleiter has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
- Gottfried Baier
Institute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria
30 shared publications - Nikolaus Thuille
Institute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria
13 shared publications - Thomas Gruber
Institute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria
11 shared publications - Victoria Klepsch
Institute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria
11 shared publications Christina Lutz-Nicoladoni
Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria
7 shared publicationsFriedrich Fresser
Department of Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria
7 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by Wiley in The FEBS Journal
- Vol. 293 (10) , 2845-2861
Limited roles of the miR ‐17‐92 cluster in the regulation of T‐cell apoptosis
The pro‐apoptotic BCL‐2‐interacting mediator of cell death [BIM; also known as Bcl‐2‐like protein 11 (BCL2L11)] is a crucial regulator of programmed cell death in immune cells, with roles in T‐cell development, homeostasis, and immune response modulation. However, the precise molecular mechanisms that regulate BIM expression in these processes are not completely understood. One possible regulatory mechanism involves microRNAs, small noncoding RNAs that silence target messenger RNAs (mRNAs). The miR‐17‐92 cluster, which has been implicated in immune regulation, has nine predicted binding sites in the 3′ untranslated region of the Bcl2l11 mRNA (thereafter referred to as Bim mRNA). To explore whether direct miR‐17‐92‐mediated regulation of BIM controls apoptosis in T cells, a genetically modified mouse model with disrupted miR‐17‐92:Bim interactions specifically in T cells has been used. The results revealed that loss of miR‐17‐92:Bim binding, although leading to a modest increase of BIM protein in double‐positive (DP) thymocytes and naïve CD8 + T cells, does not measurably affect early T‐cell development or peripheral T‐cell numbers. However, the absence of this interaction led to a moderate reduction in Th 17 CD4 + T cells at a steady state. Collectively, these findings suggest that miR‐17‐92‐mediated regulation of BIM does not play major roles in T‐cell apoptosis and homeostasis, highlighting the existence of alternative regulatory mechanisms controlling BIM pro‐apoptotic activity.
- 6 January 2026
- Published by Wiley in The FEBS Journal
- Vol. 293 (10) , 2845-2861
Open AccessLimited roles of the miR ‐17‐92 cluster in the regulation of T‐cell apoptosis
The pro‐apoptotic BCL‐2‐interacting mediator of cell death [BIM; also known as Bcl‐2‐like protein 11 (BCL2L11)] is a crucial regulator of programmed cell death in immune cells, with roles in T‐cell development, homeostasis, and immune response modulation. However, the precise molecular mechanisms that regulate BIM expression in these processes are not completely understood. One possible regulatory mechanism involves microRNAs, small noncoding RNAs that silence target messenger RNAs (mRNAs). The miR‐17‐92 cluster, which has been implicated in immune regulation, has nine predicted binding sites in the 3′ untranslated region of the Bcl2l11 mRNA (thereafter referred to as Bim mRNA). To explore whether direct miR‐17‐92‐mediated regulation of BIM controls apoptosis in T cells, a genetically modified mouse model with disrupted miR‐17‐92:Bim interactions specifically in T cells has been used. The results revealed that loss of miR‐17‐92:Bim binding, although leading to a modest increase of BIM protein in double‐positive (DP) thymocytes and naïve CD8 + T cells, does not measurably affect early T‐cell development or peripheral T‐cell numbers. However, the absence of this interaction led to a moderate reduction in Th 17 CD4 + T cells at a steady state. Collectively, these findings suggest that miR‐17‐92‐mediated regulation of BIM does not play major roles in T‐cell apoptosis and homeostasis, highlighting the existence of alternative regulatory mechanisms controlling BIM pro‐apoptotic activity.
- Open Access
- 2 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (37) , e04280
Loss of NR2F6 Protects from Salmonella Typhimurium Infection
Nuclear receptors regulate key functions of mononuclear phagocytes and are critical components of the innate immune system, acting as regulators of organ health and disease. In healthy mice, the loss of the nuclear orphan receptor NR2F6 alters tissue‐resident macrophage populations in the liver, lung, and spleen. In response to Salmonella Typhimurium infection, Nr2f6 ‐deficient mice exhibit improved clinical outcomes, characterized by reduced weight loss, bacterial loads in the spleen and liver, and decreased plasma pro‐inflammatory cytokines. Despite unchanged basal iron metabolism in the spleen and liver, iron regulatory proteins and the interleukin (IL)‐6‐hepcidin axis are altered in Nr2f6‐ deficient mice during Salmonella infection, reducing hypoferremia. Transcriptomic analysis of splenic red pulp macrophages reveals significant alterations of phagocytosis‐related genes, including upregulation of signal‐regulatory protein alpha (Sirpa). In vitro, phagocytosis of red blood cells, regulated by the inhibitory CD47‐Sirpα axis, and Salmonella Typhimurium phagocytosis are significantly impaired in Nr2f6 ‐deficient splenic macrophages. Blocking Sirpα in vitro restores the phagocytic activity of Nr2f6 ‐deficient macrophages to wild‐type levels. In vivo , Salmonella Typhimurium loads are partially increased post‐infection in anti‐Sirpα treated Nr2f6 ‐deficient mice. These findings uncover a previously unrecognized role of NR2F6 in host‐pathogen interactions, positioning it as a potential therapeutic target for infectious diseases.
- 2 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (37) , e04280
Open AccessLoss of NR2F6 Protects from Salmonella Typhimurium Infection
Nuclear receptors regulate key functions of mononuclear phagocytes and are critical components of the innate immune system, acting as regulators of organ health and disease. In healthy mice, the loss of the nuclear orphan receptor NR2F6 alters tissue‐resident macrophage populations in the liver, lung, and spleen. In response to Salmonella Typhimurium infection, Nr2f6 ‐deficient mice exhibit improved clinical outcomes, characterized by reduced weight loss, bacterial loads in the spleen and liver, and decreased plasma pro‐inflammatory cytokines. Despite unchanged basal iron metabolism in the spleen and liver, iron regulatory proteins and the interleukin (IL)‐6‐hepcidin axis are altered in Nr2f6‐ deficient mice during Salmonella infection, reducing hypoferremia. Transcriptomic analysis of splenic red pulp macrophages reveals significant alterations of phagocytosis‐related genes, including upregulation of signal‐regulatory protein alpha (Sirpa). In vitro, phagocytosis of red blood cells, regulated by the inhibitory CD47‐Sirpα axis, and Salmonella Typhimurium phagocytosis are significantly impaired in Nr2f6 ‐deficient splenic macrophages. Blocking Sirpα in vitro restores the phagocytic activity of Nr2f6 ‐deficient macrophages to wild‐type levels. In vivo , Salmonella Typhimurium loads are partially increased post‐infection in anti‐Sirpα treated Nr2f6 ‐deficient mice. These findings uncover a previously unrecognized role of NR2F6 in host‐pathogen interactions, positioning it as a potential therapeutic target for infectious diseases.
- 8 May 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (5) , e70113
Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome
Netherton syndrome (NS) is a rare ichthyosis caused by SPINK5‐null mutations, resulting in erythroderma, ichthyosis linearis circumflexa, and atopic diathesis. Elevated serum IgE levels and activation of the KLK5‐PAR2‐TSLP axis suggest involvement of Th2‐skewed immunity in NS. In this pilot study, we investigated the effects of IL‐4/IL‐13 blocking with dupilumab on NS features. At baseline, Th2‐chemokines CCL11, CCL17, CCL18, CCL26, and serum IgE were more elevated in atopic dermatitis (AD) than in NS vs. controls (ctrls). AD exhibited elevated serum levels of CCL27, LDH, and eosinophils, while NS showed higher levels of IL‐9 and IL‐18. Epidermal aberrations, including acanthosis and SC‐detachment, were present in NS versus ctrls. The number of CD3+ T cells increased, while CD1a + Langerhans cell numbers decreased in NS skin. Amounts of KLK5 were reduced, and the distribution of KLK7 was abnormal in NS epidermis as compared to ctrls. Reduced amounts of FLG, CDSN, and DSG1 highlight impaired keratinocyte late differentiation in NS. Amounts of epidermal TSLP were diminished. Upon dupilumab treatment, clinical improvement in NS began as early as week 8 and continued up to 30 months, with no serious side effects reported. Serum levels of IgE, CCL17, CCL26, IFN‐γ and IL‐18 decreased upon IL‐4/IL‐13 blockade, and alterations of cutaneous immune cells improved in NS. Furthermore, the epidermal protease inhibitor WFDC12 expression increased after dupilumab treatment, concurring with improved and partially normalised epidermal structure, including increased FLG, CDSN, and DSG1. These data highlight Th2‐skewed immunity in NS and emphasise the amelioration of NS features through dupilumab treatment.
- 8 May 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (5) , e70113
Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome
Netherton syndrome (NS) is a rare ichthyosis caused by SPINK5‐null mutations, resulting in erythroderma, ichthyosis linearis circumflexa, and atopic diathesis. Elevated serum IgE levels and activation of the KLK5‐PAR2‐TSLP axis suggest involvement of Th2‐skewed immunity in NS. In this pilot study, we investigated the effects of IL‐4/IL‐13 blocking with dupilumab on NS features. At baseline, Th2‐chemokines CCL11, CCL17, CCL18, CCL26, and serum IgE were more elevated in atopic dermatitis (AD) than in NS vs. controls (ctrls). AD exhibited elevated serum levels of CCL27, LDH, and eosinophils, while NS showed higher levels of IL‐9 and IL‐18. Epidermal aberrations, including acanthosis and SC‐detachment, were present in NS versus ctrls. The number of CD3+ T cells increased, while CD1a + Langerhans cell numbers decreased in NS skin. Amounts of KLK5 were reduced, and the distribution of KLK7 was abnormal in NS epidermis as compared to ctrls. Reduced amounts of FLG, CDSN, and DSG1 highlight impaired keratinocyte late differentiation in NS. Amounts of epidermal TSLP were diminished. Upon dupilumab treatment, clinical improvement in NS began as early as week 8 and continued up to 30 months, with no serious side effects reported. Serum levels of IgE, CCL17, CCL26, IFN‐γ and IL‐18 decreased upon IL‐4/IL‐13 blockade, and alterations of cutaneous immune cells improved in NS. Furthermore, the epidermal protease inhibitor WFDC12 expression increased after dupilumab treatment, concurring with improved and partially normalised epidermal structure, including increased FLG, CDSN, and DSG1. These data highlight Th2‐skewed immunity in NS and emphasise the amelioration of NS features through dupilumab treatment.
- Open Access
- 7 February 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-14
Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6
Natural killer (NK) cell development and functionality rely on precise regulation by specific transcription factors (TFs). Our study demonstrates that the nuclear orphan receptor NR2F6 represses the expression of the activating receptor NKp46, an established key player in NK cell-mediated cytotoxicity during infection and tumor rejection. Despite normal NK cell development in the bone marrow, germline Nr2f6-deficient mice exhibit impaired terminal maturation of NK cells in the periphery. Short-term NK cell responses to lipopolysaccharide (LPS) activation, independent of NKp46, are subsequently reduced in Nr2f6-deficient mice. Conventional type 1 dendritic cells (cDC1) and macrophage populations are decreased in spleens of Nr2f6-deficient mice, subsequently, IL-15-dependent NK cell priming is limited. Administration of exogenous IL-15 in vitro and as IL-15 complex in vivo can compensate for these deficits, promoting terminal maturation of NK cells in Nr2f6-deficient mice. Subsequent transcriptome analysis reveals significant changes in gene expression profiles of NK cells from IL-15 complex treated Nr2f6-deficient mice, with notable alterations in essential NK genes such as Klrg1, Prdm1, Stat5a, Zeb2, and Prf1. Consequently, Nr2f6-deficient IL-15 complex-treated NK cells raise enhanced effector responses of IFNγ, Perforin, and Granzyme B upon ex vivo activation. Of importance, Nr2f6-deficient mice are protected against MHC-I negative B16-F10 melanoma lung metastasis formation, especially with IL-15 complex treatment, indicating the potential of NR2F6 to affect NKp46-dependent NK cell-mediated tumor surveillance. The therapeutic targeting of NR2F6 may be a promising strategy for boosting NKp46-dependent NK-cell-mediated tumor surveillance and metastasis.
- 7 February 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-14
Open AccessRegulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6
Natural killer (NK) cell development and functionality rely on precise regulation by specific transcription factors (TFs). Our study demonstrates that the nuclear orphan receptor NR2F6 represses the expression of the activating receptor NKp46, an established key player in NK cell-mediated cytotoxicity during infection and tumor rejection. Despite normal NK cell development in the bone marrow, germline Nr2f6-deficient mice exhibit impaired terminal maturation of NK cells in the periphery. Short-term NK cell responses to lipopolysaccharide (LPS) activation, independent of NKp46, are subsequently reduced in Nr2f6-deficient mice. Conventional type 1 dendritic cells (cDC1) and macrophage populations are decreased in spleens of Nr2f6-deficient mice, subsequently, IL-15-dependent NK cell priming is limited. Administration of exogenous IL-15 in vitro and as IL-15 complex in vivo can compensate for these deficits, promoting terminal maturation of NK cells in Nr2f6-deficient mice. Subsequent transcriptome analysis reveals significant changes in gene expression profiles of NK cells from IL-15 complex treated Nr2f6-deficient mice, with notable alterations in essential NK genes such as Klrg1, Prdm1, Stat5a, Zeb2, and Prf1. Consequently, Nr2f6-deficient IL-15 complex-treated NK cells raise enhanced effector responses of IFNγ, Perforin, and Granzyme B upon ex vivo activation. Of importance, Nr2f6-deficient mice are protected against MHC-I negative B16-F10 melanoma lung metastasis formation, especially with IL-15 complex treatment, indicating the potential of NR2F6 to affect NKp46-dependent NK cell-mediated tumor surveillance. The therapeutic targeting of NR2F6 may be a promising strategy for boosting NKp46-dependent NK-cell-mediated tumor surveillance and metastasis.
- Open Access
- 7 January 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1404805
NR2F6 regulates stem cell hematopoiesis and myelopoiesis in mice
Nuclear receptors regulate hematopoietic stem cells (HSCs) and peripheral immune cells in mice and humans. The nuclear orphan receptor NR2F6 (EAR-2) has been shown to control murine hematopoiesis. Still, detailed analysis of the distinct stem cell, myeloid, and lymphoid progenitors in the bone marrow in a genetic loss of function model remains pending. In this study, we found that adult germline Nr2f6-deficient mice contained increased percentages of total long-term and short-term HSCs, as well as a subpopulation within the lineage-biased multipotent progenitor (MPP3) cells. The loss of NR2F6 thus led to an increase in the percentage of LSK+ cells. Following the differentiation from the common myeloid progenitors (CMP), the granulocyte-monocyte progenitors (GMP) were decreased, while monocyte-dendritic progenitors (MDP) were increased in Nr2f6-deficient bone marrow. Within the pre-conventional dendritic progenitors (pre-cDCs), the subpopulation of pre-cDC2s was reduced in the bone marrow of Nr2f6-deficient mice. We did not observe differences in the development of common lymphoid progenitor populations. Our findings contrast previous studies but underscore the role of NR2F6 in regulating gene expression levels during mouse bone marrow hematopoiesis and myelopoiesis.
- 7 January 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1404805
Open AccessNR2F6 regulates stem cell hematopoiesis and myelopoiesis in mice
Nuclear receptors regulate hematopoietic stem cells (HSCs) and peripheral immune cells in mice and humans. The nuclear orphan receptor NR2F6 (EAR-2) has been shown to control murine hematopoiesis. Still, detailed analysis of the distinct stem cell, myeloid, and lymphoid progenitors in the bone marrow in a genetic loss of function model remains pending. In this study, we found that adult germline Nr2f6-deficient mice contained increased percentages of total long-term and short-term HSCs, as well as a subpopulation within the lineage-biased multipotent progenitor (MPP3) cells. The loss of NR2F6 thus led to an increase in the percentage of LSK+ cells. Following the differentiation from the common myeloid progenitors (CMP), the granulocyte-monocyte progenitors (GMP) were decreased, while monocyte-dendritic progenitors (MDP) were increased in Nr2f6-deficient bone marrow. Within the pre-conventional dendritic progenitors (pre-cDCs), the subpopulation of pre-cDC2s was reduced in the bone marrow of Nr2f6-deficient mice. We did not observe differences in the development of common lymphoid progenitor populations. Our findings contrast previous studies but underscore the role of NR2F6 in regulating gene expression levels during mouse bone marrow hematopoiesis and myelopoiesis.
- Open Access
- 16 August 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 845235
A role for the nuclear receptor NR2F6 in peritoneal B cell homeostasis
B cells are key mediators of humoral immunity. Mature B cells fall into various sub-classes that can be separated by their ontogeny, expression of cell surface markers, anatomical location, and function. B1 subsets play important roles in natural immunity and constitute the majority of B cells in newborns. In the adult, B1 cells predominate in the pleural and peritoneal cavities, while the mature B2 follicular subset makes up the major fraction of B cells in lymphoid tissue, although important subsets of antibody-secreting B1 cells are also present at these sites. B1 cells are the main producers of natural IgM but can also contribute to elimination of some pathogens, while B2 cells primarily mediate response to foreign antigens. The differential molecular underpinning of the B1 and B2 subsets remains incompletely understood. Here we demonstrate that germline-deficiency of the orphan nuclear receptor NR2F6 causes a partial loss of B1b and B2 B cells in the peritoneum while leaving peritoneal B1a cells unaltered. A competitive bone marrow chimera in Nr2f6+/+ host mice produced similar numbers of Nr2f6+/+ and Nr2f6-/- peritoneal B1b and B2 cells. The proliferation of Nr2f6-/- peritoneal B cells was not altered, while the migration marker CXCR5 was reduced on all subsets but Beta7-integrin was reduced only on peritoneal B1b and B2 cells. Similarly, B1b and B2 but not B1a cells, exhibited significantly reduced survival.
- 16 August 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 845235
Open AccessA role for the nuclear receptor NR2F6 in peritoneal B cell homeostasis
B cells are key mediators of humoral immunity. Mature B cells fall into various sub-classes that can be separated by their ontogeny, expression of cell surface markers, anatomical location, and function. B1 subsets play important roles in natural immunity and constitute the majority of B cells in newborns. In the adult, B1 cells predominate in the pleural and peritoneal cavities, while the mature B2 follicular subset makes up the major fraction of B cells in lymphoid tissue, although important subsets of antibody-secreting B1 cells are also present at these sites. B1 cells are the main producers of natural IgM but can also contribute to elimination of some pathogens, while B2 cells primarily mediate response to foreign antigens. The differential molecular underpinning of the B1 and B2 subsets remains incompletely understood. Here we demonstrate that germline-deficiency of the orphan nuclear receptor NR2F6 causes a partial loss of B1b and B2 B cells in the peritoneum while leaving peritoneal B1a cells unaltered. A competitive bone marrow chimera in Nr2f6+/+ host mice produced similar numbers of Nr2f6+/+ and Nr2f6-/- peritoneal B1b and B2 cells. The proliferation of Nr2f6-/- peritoneal B cells was not altered, while the migration marker CXCR5 was reduced on all subsets but Beta7-integrin was reduced only on peritoneal B1b and B2 cells. Similarly, B1b and B2 but not B1a cells, exhibited significantly reduced survival.
- Open Access
- 19 April 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-12
Addressing the role of PKD3 in the T cell compartment with knockout mice
Background: The Protein kinase D3 (PKD3) has been implicated in signal transduction downstream of the T cell receptor (TCR). However, its role for the activation of primary T lymphocytes has not been elucidated so far. Methods: Expression of PKD isoforms in primary murine T cells was determined by RT-PCR and SDS-Page. A germline PKD3-knockout mouse line was analyzed for its immune response to OVA/alum intraperitoneal immunization. Phenotyping of the T cell compartment ex vivo as well as upon stimulation in vitro was performed by flow cytometry. Additionally, cytokine expression was assessed by flow cytometry, RT-PCR and Luminex technology. Results: PKD expression in T cells is modulated by TCR stimulation, leading to a rapid down-regulation on mRNA and on protein level. PKD3-deficient mice respond to immunization with enhanced T follicular helper cell generation. Furthermore, peripheral PKD3-deficient CD4+ T cells express more interleukin-2 than wild type CD4+ T cells upon TCR stimulation ex vivo. However, purified naïve CD4+ T cells do not differ in their phenotype upon differentiation in vitro from wild type T cells. Moreover, we observed a shift towards an effector/memory phenotype of splenic T cells at steady state, which might explain the contradictory results obtained with pan-T cells ex vivo and naïve-sorted T cells. Conclusion: While PKD3-deficiency in vivo in mice leads to a skewing of the T cell compartment towards a more activated phenotype, this kinase seems to be dispensable for naïve CD4+ T cell differentiation in vitro.
- 19 April 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-12
Open AccessAddressing the role of PKD3 in the T cell compartment with knockout mice
Background: The Protein kinase D3 (PKD3) has been implicated in signal transduction downstream of the T cell receptor (TCR). However, its role for the activation of primary T lymphocytes has not been elucidated so far. Methods: Expression of PKD isoforms in primary murine T cells was determined by RT-PCR and SDS-Page. A germline PKD3-knockout mouse line was analyzed for its immune response to OVA/alum intraperitoneal immunization. Phenotyping of the T cell compartment ex vivo as well as upon stimulation in vitro was performed by flow cytometry. Additionally, cytokine expression was assessed by flow cytometry, RT-PCR and Luminex technology. Results: PKD expression in T cells is modulated by TCR stimulation, leading to a rapid down-regulation on mRNA and on protein level. PKD3-deficient mice respond to immunization with enhanced T follicular helper cell generation. Furthermore, peripheral PKD3-deficient CD4+ T cells express more interleukin-2 than wild type CD4+ T cells upon TCR stimulation ex vivo. However, purified naïve CD4+ T cells do not differ in their phenotype upon differentiation in vitro from wild type T cells. Moreover, we observed a shift towards an effector/memory phenotype of splenic T cells at steady state, which might explain the contradictory results obtained with pan-T cells ex vivo and naïve-sorted T cells. Conclusion: While PKD3-deficiency in vivo in mice leads to a skewing of the T cell compartment towards a more activated phenotype, this kinase seems to be dispensable for naïve CD4+ T cell differentiation in vitro.
- Open Access
- 15 February 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (2) , 1-16
Loss of the orphan nuclear receptor NR2F6 enhances CD8+ T-cell memory via IFN-γ
Memory formation is a hallmark of T cell-mediated immunity, but how differentiation into either short-lived effector cells (SLECs, CD127−KLRG1+) or memory precursors cells (MPECs, CD127+KLRG1−) and subsequent regulation of long-term memory is adjusted is incompletely understood. Here, we show that loss of the nuclear orphan receptor NR2F6 in germ-line Nr2f6-deficient mice enhances antigen-specific CD8+ memory formation up to 70 days after bacterial infection with Listeria monocytogenes (LmOVA) and boosts inflammatory IFN-γ, TNFα, and IL-2 cytokine recall responses. Adoptive transfer experiments using Nr2f6−/− OT-I T-cells showed that the augmented memory formation is CD8+ T-cell intrinsic. Although the relative difference between the Nr2f6+/+ and Nr2f6−/− OT-I memory compartment declines over time, Nr2f6-deficient OT-I memory T cells mount significantly enhanced IFN-γ responses upon reinfection with increased clonal expansion and improved host antigen-specific CD8+ T-cell responses. Following a secondary adoptive transfer into naïve congenic mice, Nr2f6-deficient OT-I memory T cells are superior in clearing LmOVA infection. Finally, we show that the commitment to enhanced memory within Nr2f6-deficient OT-I T cells is established in the early phases of the antibacterial immune response and is IFN-γ mediated. IFN-γ blocking normalized MPEC formation of Nr2f6-deficient OT-I T cells. Thus, deletion or pharmacological inhibition of NR2F6 in antigen-specific CD8+ T cells may have therapeutic potential for enhancing early IFN-γ production and consequently the functionality of memory CD8+ T cells in vivo.
- 15 February 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (2) , 1-16
Open AccessLoss of the orphan nuclear receptor NR2F6 enhances CD8+ T-cell memory via IFN-γ
Memory formation is a hallmark of T cell-mediated immunity, but how differentiation into either short-lived effector cells (SLECs, CD127−KLRG1+) or memory precursors cells (MPECs, CD127+KLRG1−) and subsequent regulation of long-term memory is adjusted is incompletely understood. Here, we show that loss of the nuclear orphan receptor NR2F6 in germ-line Nr2f6-deficient mice enhances antigen-specific CD8+ memory formation up to 70 days after bacterial infection with Listeria monocytogenes (LmOVA) and boosts inflammatory IFN-γ, TNFα, and IL-2 cytokine recall responses. Adoptive transfer experiments using Nr2f6−/− OT-I T-cells showed that the augmented memory formation is CD8+ T-cell intrinsic. Although the relative difference between the Nr2f6+/+ and Nr2f6−/− OT-I memory compartment declines over time, Nr2f6-deficient OT-I memory T cells mount significantly enhanced IFN-γ responses upon reinfection with increased clonal expansion and improved host antigen-specific CD8+ T-cell responses. Following a secondary adoptive transfer into naïve congenic mice, Nr2f6-deficient OT-I memory T cells are superior in clearing LmOVA infection. Finally, we show that the commitment to enhanced memory within Nr2f6-deficient OT-I T cells is established in the early phases of the antibacterial immune response and is IFN-γ mediated. IFN-γ blocking normalized MPEC formation of Nr2f6-deficient OT-I T cells. Thus, deletion or pharmacological inhibition of NR2F6 in antigen-specific CD8+ T cells may have therapeutic potential for enhancing early IFN-γ production and consequently the functionality of memory CD8+ T cells in vivo.
- 1 January 2021
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 11 (23) , e4247
Bacterial Infection with Listeria monocytogenes in Mice and Subsequent Analysis of AntigenSpecific CD8 T Cell Responses
Pathogens such as bacteria, viruses, fungi, or protozoa can cause acute and chronic infections in their hosts. The intracellular bacterium Listeria monocytogenes serves as a model pathogen to assess the molecular mechanisms regulating CD8 T cell activation, differentiation, and function. We set up an experimental workflow to investigate cell-intrinsic roles of the nuclear receptor NR2F6 in CD8 T cell memory formation upon Listeria monocytogenes (LmOVA) infection (Jakic et al., 2021). The current protocol details how to cultivate ovalbumin-expressing LmOVA, infect naïve C57BL/6 mice with these bacteria and determine the bacterial load in host organs. Furthermore, we describe how to evaluate antigen-specific CD8 T cell responses and discriminate between short-lived effector and memory precursor cells in vivo following LmOVA infection (Figure 1). To assess CD8 T cell-intrinsic molecular mechanisms, we integrated an adoptive cell transfer (ACT) experiment of genetically modified naïve OT-I CD8 T cells into congenic hosts before LmOVA infection.Graphic Figure 1. Experimental workflow depicting the steps for infection of mice with Listeria and subsequent analysis of antigen-specific CD8 memory responses.Bacteria (ovalbumin expressing Listeria monocytogenes) are thawed and grown on lysogeny broth (LB) plates overnight (ON). A single colony is picked and grown in LB medium ON. Bacteria from the exponential growth phase are then injected into a C57BL/6 mouse via tail vein injection. Colony forming units (CFU) of the bacteria can be detected in the spleen on day 3 post injection. Antigen-specific CD8 T cell immune response can be investigated during the acute phase (d3 after infection), during the peak of the adaptive immune response (d7), the clearance phase (d26), or the memory phase (d70) by flow cytometry. Created with BioRender.com., [摘要]细菌、病毒、真菌或原生动物等病原体可在宿主中引起急性和慢性感染。细胞内细菌单核细胞增生李斯特菌作为模型病原体来评估调节 CD8 T 细胞活化、分化和功能的分子机制。我们建立了一个实验工作流程来研究核受体 NR2F6 在单核细胞增生李斯特菌(LmOVA) 感染后 CD8 T 细胞记忆形成中的细胞内在作用(Jakic等人,2021 年)。目前的协议详细说明了如何培养表达卵白蛋白的 LmOVA,用这些细菌感染幼稚的 C57BL/6 小鼠,并确定宿主器官中的细菌负荷。此外,我们描述了如何评估抗原特异性 CD8 T 细胞反应,并在LmOVA 感染后区分体内短寿命效应细胞和记忆前体细胞(图 1)。为了评估 CD8 T 细胞内在分子机制,我们在 LmOVA感染之前将转基因幼稚 OT-I CD8 T 细胞的过继细胞转移 (ACT) 实验整合到同类宿主中。图形摘要:图 1.实验工作流程描述了用李斯特菌感染小鼠的步骤以及随后对抗原特异性 CD8 记忆反应的分析。细菌(表达单核细胞增生李斯特菌的卵清蛋白)在溶原性肉汤(LB)板上解冻并生长过夜(ON)。挑选单个菌落并在 LB 培养基 ON 中生长。然后通过尾静脉注射将指数生长期的细菌注射到 C57BL/6 小鼠中。在注射后第 3 天,可以在脾脏中检测到细菌的菌落形成单位 (CFU)。可以通过流式细胞术在急性期(感染后 d3)、适应性免疫反应高峰期(d7)、清除期(d26)或记忆期(d70)期间研究抗原特异性 CD8 T 细胞免疫反应. 使用 BioRender.com 创建。[背景] 单核细胞增生李斯特菌(Lm) 是一种革兰氏阳性兼性细胞内细菌病原体,是李斯特菌病的病原体(Hamon等,2006;Khan 和 Badovinac,2015)。自 1950 年代以来,鼠李斯特菌病一直是定义明确的小鼠感染模型(Osebold 和 Sawyer,1957)。先天性和适应性免疫细胞对于消除这些细菌都至关重要(Zenewicz 和 Shen,2007)。细胞对 Lm感染的反应具有高度可重复性,并且宿主中的细菌负荷很容易量化。在亚致死剂量下(LmOVA 的LD 50剂量:~5 × 10 6 CFU),Lm诱导强大的免疫反应,这依赖于 T 细胞依赖性细菌清除(Zenewicz 和 Shen,2007)。因此,除了淋巴细胞脉络丛脑膜炎病毒 (LCMV) 感染之外,50多年来,Lm 的全身性细菌感染一直是表征病原体特异性 CD8 T 细胞效应子反应和记忆形成的首选方法(Mackaness,1962 年;Harty 和Bevan,1995;Shen等,1998;Badovinac等,2000;Khan 和 Badovinac,2015;Qiu等,2018;Levine等,2021)。Lm通过胃肠道自然感染大多数哺乳动物宿主 (Pamer, 2004)。然而,与人类相反,小鼠 E-钙粘蛋白在口服感染时不允许内在依赖性进入胃肠道上皮细胞(Lecuit等,1999)。在小鼠中进行静脉接种后,Lm 被脾脏和肝脏巨噬细胞从血流中吸收,这些巨噬细胞将细菌运送到淋巴器官的 T 细胞区(Merrick等,1997;Pamer,2004)。 近交小鼠品系,如 C57BL/6 或 BALB/c,对 Lm 感染的反应是不同的 MHC I 类 (CD8) 或 MHC II 类 (CD4) 表位。对 MHC-II 限制性表位李斯特菌溶血素O (LLO) 190-201的反应主要在 C57BL/6 小鼠中观察到,对 MHC-I 限制性表位 LLO 91-99和 p60 217-225的反应在 BALB 中占主导地位/c 小鼠(Pamer等,1991 和 1994)(Zenewicz 和 Shen,2007)。此外,Lm已成功设计为表达新的 H2-K b表位(Zenewicz 和 Shen,2007)。其他致病性减弱的菌株允许在免疫功能低下的小鼠中使用这种细菌,抗生素和发光报告基因对感染持续时间的操纵使实验选择多样化(Schmidt等,2012)。一种特别有用的 Lm菌株已被改造以表达模型抗原卵清蛋白 (OVA)(Pope等,2001;Foulds等,2002)。这种 LmOVA 菌株与一系列动物模型兼容,例如 T 细胞受体 (TCR) 转基因 OT-I 小鼠和强大的免疫学工具,例如用于检测抗原特异性 CD8 T 细胞的...
- 1 January 2021
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 11 (23) , e4247
Bacterial Infection with Listeria monocytogenes in Mice and Subsequent Analysis of AntigenSpecific CD8 T Cell Responses
Pathogens such as bacteria, viruses, fungi, or protozoa can cause acute and chronic infections in their hosts. The intracellular bacterium Listeria monocytogenes serves as a model pathogen to assess the molecular mechanisms regulating CD8 T cell activation, differentiation, and function. We set up an experimental workflow to investigate cell-intrinsic roles of the nuclear receptor NR2F6 in CD8 T cell memory formation upon Listeria monocytogenes (LmOVA) infection (Jakic et al., 2021). The current protocol details how to cultivate ovalbumin-expressing LmOVA, infect naïve C57BL/6 mice with these bacteria and determine the bacterial load in host organs. Furthermore, we describe how to evaluate antigen-specific CD8 T cell responses and discriminate between short-lived effector and memory precursor cells in vivo following LmOVA infection (Figure 1). To assess CD8 T cell-intrinsic molecular mechanisms, we integrated an adoptive cell transfer (ACT) experiment of genetically modified naïve OT-I CD8 T cells into congenic hosts before LmOVA infection.Graphic Figure 1. Experimental workflow depicting the steps for infection of mice with Listeria and subsequent analysis of antigen-specific CD8 memory responses.Bacteria (ovalbumin expressing Listeria monocytogenes) are thawed and grown on lysogeny broth (LB) plates overnight (ON). A single colony is picked and grown in LB medium ON. Bacteria from the exponential growth phase are then injected into a C57BL/6 mouse via tail vein injection. Colony forming units (CFU) of the bacteria can be detected in the spleen on day 3 post injection. Antigen-specific CD8 T cell immune response can be investigated during the acute phase (d3 after infection), during the peak of the adaptive immune response (d7), the clearance phase (d26), or the memory phase (d70) by flow cytometry. Created with BioRender.com., [摘要]细菌、病毒、真菌或原生动物等病原体可在宿主中引起急性和慢性感染。细胞内细菌单核细胞增生李斯特菌作为模型病原体来评估调节 CD8 T 细胞活化、分化和功能的分子机制。我们建立了一个实验工作流程来研究核受体 NR2F6 在单核细胞增生李斯特菌(LmOVA) 感染后 CD8 T 细胞记忆形成中的细胞内在作用(Jakic等人,2021 年)。目前的协议详细说明了如何培养表达卵白蛋白的 LmOVA,用这些细菌感染幼稚的 C57BL/6 小鼠,并确定宿主器官中的细菌负荷。此外,我们描述了如何评估抗原特异性 CD8 T 细胞反应,并在LmOVA 感染后区分体内短寿命效应细胞和记忆前体细胞(图 1)。为了评估 CD8 T 细胞内在分子机制,我们在 LmOVA感染之前将转基因幼稚 OT-I CD8 T 细胞的过继细胞转移 (ACT) 实验整合到同类宿主中。图形摘要:图 1.实验工作流程描述了用李斯特菌感染小鼠的步骤以及随后对抗原特异性 CD8 记忆反应的分析。细菌(表达单核细胞增生李斯特菌的卵清蛋白)在溶原性肉汤(LB)板上解冻并生长过夜(ON)。挑选单个菌落并在 LB 培养基 ON 中生长。然后通过尾静脉注射将指数生长期的细菌注射到 C57BL/6 小鼠中。在注射后第 3 天,可以在脾脏中检测到细菌的菌落形成单位 (CFU)。可以通过流式细胞术在急性期(感染后 d3)、适应性免疫反应高峰期(d7)、清除期(d26)或记忆期(d70)期间研究抗原特异性 CD8 T 细胞免疫反应. 使用 BioRender.com 创建。[背景] 单核细胞增生李斯特菌(Lm) 是一种革兰氏阳性兼性细胞内细菌病原体,是李斯特菌病的病原体(Hamon等,2006;Khan 和 Badovinac,2015)。自 1950 年代以来,鼠李斯特菌病一直是定义明确的小鼠感染模型(Osebold 和 Sawyer,1957)。先天性和适应性免疫细胞对于消除这些细菌都至关重要(Zenewicz 和 Shen,2007)。细胞对 Lm感染的反应具有高度可重复性,并且宿主中的细菌负荷很容易量化。在亚致死剂量下(LmOVA 的LD 50剂量:~5 × 10 6 CFU),Lm诱导强大的免疫反应,这依赖于 T 细胞依赖性细菌清除(Zenewicz 和 Shen,2007)。因此,除了淋巴细胞脉络丛脑膜炎病毒 (LCMV) 感染之外,50多年来,Lm 的全身性细菌感染一直是表征病原体特异性 CD8 T 细胞效应子反应和记忆形成的首选方法(Mackaness,1962 年;Harty 和Bevan,1995;Shen等,1998;Badovinac等,2000;Khan 和 Badovinac,2015;Qiu等,2018;Levine等,2021)。Lm通过胃肠道自然感染大多数哺乳动物宿主 (Pamer, 2004)。然而,与人类相反,小鼠 E-钙粘蛋白在口服感染时不允许内在依赖性进入胃肠道上皮细胞(Lecuit等,1999)。在小鼠中进行静脉接种后,Lm 被脾脏和肝脏巨噬细胞从血流中吸收,这些巨噬细胞将细菌运送到淋巴器官的 T 细胞区(Merrick等,1997;Pamer,2004)。 近交小鼠品系,如 C57BL/6 或 BALB/c,对 Lm 感染的反应是不同的 MHC I 类 (CD8) 或 MHC II 类 (CD4) 表位。对 MHC-II 限制性表位李斯特菌溶血素O (LLO) 190-201的反应主要在 C57BL/6 小鼠中观察到,对 MHC-I 限制性表位 LLO 91-99和 p60 217-225的反应在 BALB 中占主导地位/c 小鼠(Pamer等,1991 和 1994)(Zenewicz 和 Shen,2007)。此外,Lm已成功设计为表达新的 H2-K b表位(Zenewicz 和 Shen,2007)。其他致病性减弱的菌株允许在免疫功能低下的小鼠中使用这种细菌,抗生素和发光报告基因对感染持续时间的操纵使实验选择多样化(Schmidt等,2012)。一种特别有用的 Lm菌株已被改造以表达模型抗原卵清蛋白 (OVA)(Pope等,2001;Foulds等,2002)。这种 LmOVA 菌株与一系列动物模型兼容,例如 T 细胞受体 (TCR) 转基因 OT-I 小鼠和强大的免疫学工具,例如用于检测抗原特异性 CD8 T 细胞的...
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (1) , 84-94.e6
Notch-Mediated Generation of Monocyte-Derived Langerhans Cells: Phenotype and Function
- 1 January 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (1) , 84-94.e6
Open AccessNotch-Mediated Generation of Monocyte-Derived Langerhans Cells: Phenotype and Function